2022

• Ting, S., Zhao, C., Cook, D. (2022). Subcutaneous Sweet syndrome leading to the diagnosis of acute myeloid leukaemia. Australian Journal of General Practice, 51(6), 391-393. [More Information]

2021

• Jiang, K., Zhao, C., Chan, C., Peduto, M., Kailainathan, G., Cook, D. (2021). Eruptive Bowen's Disease in a patient on pembrolizumab for Hodgkin's lymphoma. Australasian Journal of Dermatology, 62(3), e435-e437. [More Information]
• Sun, H., Kandasamy, M., Zhao, C., Makhija, M., Sebaratnam, D. (2021). Stewart-Bluefarb syndrome following traumatic arteriovenous malformation. Pediatric Dermatology, 38(3), 709-711. [More Information]

2020

• Zhao, C., Consuegra Romero, G. (2020). Flagellate erythema: from diet, drugs to dermatomyositis. Medical Journal of Australia, 213(8), 354. [More Information]
• Zhao, C., Kim, J., Fernandez Penas, P. (2020). Widespread nodules and papules in a patient with chronic myelomonocytic leukemia. International Journal Of Dermatology, 59(9), 1071-1072. [More Information]

2018

• Zhao, C., Hwang, S., Consuegra, G., Chou, S., Fernandez Penas, P. (2018). Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature. Melanoma Research, 28(6), 491-501. [More Information]
• Zhao, C., Liu, R., Consuegra Romero, G., Hui, R., Fernandez Penas, P. (2018). Epidermal growth factor receptor inhibitor-induced papulopustular eruption successfully treated with low-dose oral dapsone. Australasian Journal of Dermatology, 59(3), e219-e220. [More Information]
• Zhao, C., Hwang, S., Anforth, R., Carlos, G., Chou, S., Carlino, M., Fernandez Penas, P. (2018). Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma. Journal of Immunotherapy, 41(7), 343-349. [More Information]
• Zhao, C., Fernandez Penas, P. (2018). Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas. Australasian Journal of Dermatology, 59(4), e297-e298. [More Information]
• Zhao, C., Chou, S., Liu, R., Fernandez Penas, P. (2018). Naevus lightening in melanoma patients under BRAF/MEK inhibitor combination therapy versus checkpoint immunotherapy: A histological and immunohistochemistry analysis. Pigment Cell & Melanoma Research, 31(2), 341-344. [More Information]

2017

• Zhao, C., Consuegra Romero, G., Chou, S., Fernandez Penas, P. (2017). Intracorneal pustular drug eruption, a novel cutaneous adverse event in anti-programmed cell death-1 patients that highlights the effect of anti-programmed cell death-1 in neutrophils. Melanoma Research, 27(6), 641-644. [More Information]
• Zhao, C., Hwang, S., Wakade, D., Carlos, G., Anforth, R., Fernandez Penas, P. (2017). Melanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational study. Australasian Journal of Dermatology, 58(4), 292-298. [More Information]
• Chou, S., Zhao, C., Hwang, S., Fernandez Penas, P. (2017). PD-1 inhibitor-associated lichenoid inflammation with incidental suprabasilar acantholysis or vesiculation—Report of 4 cases. Journal Of Cutaneous Pathology, 44(10), 851-856. [More Information]

2014

• Cheung, W., Sahai, V., Mann - Farrar, J., Skylas, K., Uy, J., Doyle, B., Cavalletto, A., Martin, H., Schiemer, A., Spiker, C., et al (2014). Incidents resulting from staff leaving normal duties to attend medical emergency team calls. Medical Journal of Australia, 201(9), 528-531. [More Information]
• Wu, H., Steenstra, R., de Boer, E., Zhao, C., Ma, J., van der Stelt, J., Chadban, S. (2014). Preconditioning with recombinant high-mobility group box 1 protein protects the kidney against ischemia-reperfusion injury in mice. Kidney International, 85(4), 824-832. [More Information]
• Ma, J., Wu, H., Zhao, C., Panchapakesan, U., Pollock, C., Chadban, S. (2014). Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy. International Journal of Clinical and Experimental Pathology, 7(2), 481-495.
• Ma, J., Chadban, S., Zhao, C., Chen, X., Kwan, T., Panchapakesan, U., Pollock, C., Wu, H. (2014). TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy. PloS One, 9(5), 1-12. [More Information]

2012

• Wu, H., Noordmans, G., O'Brien, M., Ma, J., Zhao, C., Zhang, G., Kwan, T., Alexander, S., Chadban, S. (2012). Absence of MyD88 Signaling Induces Donor-Specific Kidney Allograft Tolerance. Journal of the American Society of Nephrology, 23(10), 1701-1716. [More Information]